Kellum Stem Cell Institute in Tennessee offers innovative stem cell therapies targeting chronic lung diseases such as COPD, pulmonary fibrosis, and asthma. Utilizing the patient's own mesenchymal stem cells (MSCs) derived from adipose or bone marrow tissue, the institute aims to reduce inflammation, promote tissue regeneration, and enhance lung function. These treatments provide a promising alternative to traditional interventions, focusing on healing and improving overall respiratory health.
https://kellumstemcellinstitute.com/stem-cell-therapies/lung-disease/
Przesłana zawartość zostanie przeniesiona do tego nowo utworzonego albumu. Musisz utwórz konto lub zaloguj, jeśli chcesz edytować ten album później.